Evaluation of Effectiveness and Safety of Rotational Atherectomy in Routine Clinical Practice
NCT ID: NCT03427996
Last Updated: 2024-12-27
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
500 participants
OBSERVATIONAL
2018-09-04
2034-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Keywords
Explore important study keywords that can help with search, categorization, and topic discovery.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Coronary disease
Rotational atherectomy
Percutaneous coronary intervention with rotational atherectomy
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Rotational atherectomy
Percutaneous coronary intervention with rotational atherectomy
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Patients who received rotational atherectomy
* The patient or guardian agrees to the study protocol and the schedule of clinical follow-up and provides informed, written consent, as approved by the appropriate Institutional Review Board/Ethics Committee of the respective clinical site.
Exclusion Criteria
19 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
CardioVascular Research Foundation, Korea
OTHER
Seung-Jung Park
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Seung-Jung Park
Professor, Division of Cardiology
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Soon Chun Hyang University Hospital Bucheon
Bucheon-si, , South Korea
Daegu Catholic University Medical Center
Daegu, , South Korea
Chungnam National University Hospital
Daejeon, , South Korea
The Catholic University of Korea, Daejeon ST. Mary's Hospital
Daejeon, , South Korea
Chonnam National University Hospital
Gwangju, , South Korea
Inje University Pusan Paik Hospital
Pusan, , South Korea
Bundang CHA Hospital
Seongnam, , South Korea
Asan Medical Center
Seoul, , South Korea
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Nae-Hee Lee, MD
Role: primary
Kee-Sik Kim, MD
Role: primary
Young-jun Hong, MD
Role: primary
Seung-jung Park, MD
Role: primary
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
AMCCV2018-02
Identifier Type: -
Identifier Source: org_study_id